Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment.

Aishah A EkhzaimyAfshan MasoodAfshan MasoodTasnem ElhassanMohthash MusambilAssim A Alfadda

Published in: Diabetes & vascular disease research (2022)

Liraglutide treatment decreased levels of acute phase response that to reduce the systemic chronic inflammatory state and oxidative stress, and eventually improve the cardio-metabolic profile in these patients.

Keyphrases

oxidative stress
newly diagnosed
mass spectrometry
dna damage
prognostic factors
chronic kidney disease
signaling pathway
diabetic rats
patient reported